Texas OK’s $50 Million for Ibogaine Research

Health
By Andrew Jacobs from NYT Health https://ift.tt/neAzcVE
via IFTTT Mental Health and Disorders, United States Politics and Government, Regulation and Deregulation of Industry, Therapy and Rehabilitation, Psychiatry and Psychiatrists, Law and Legislation, Clinical Trials, Psychedelic and Hallucinogenic Drugs, Drugs (Pharmaceuticals), Depression (Mental), Research, Traumatic Brain Injury, Addiction (Psychology), Opioids and Opiates, Veterans The state’s governor signed legislation to allow clinical trials of a psychedelic drug that shows promise for veterans in treating addiction and post-traumatic stress disorder.

Comments

Post a Comment

Popular posts from this blog

F.D.A. Poised to Restrict Access to Covid Vaccines

Image
Health By Christina Jewett and Apoorva Mandavilli from NYT Health https://ift.tt/VHvAQN8 via IFTTT Vaccination and Immunization, Coronavirus (2019-nCoV), Regulation and Deregulation of Industry, Rumors and Misinformation, Clinical Trials, Medicine and Health Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many others may not be able to get the shots.
Read more

U.S. Will No Longer Recommend Covid Shots for Children and Pregnant Women

Image
Health By Apoorva Mandavilli and Christina Jewett from NYT Health https://ift.tt/lefLSPp via IFTTT Vaccination and Immunization, Children and Childhood, United States Politics and Government, Regulation and Deregulation of Industry, Babies and Infants, Pregnancy and Childbirth, Coronavirus (2019-nCoV) Health Secretary Robert F. Kennedy Jr. announced that the vaccine would not be included as part of the immunization schedule for healthy children.
Read more